- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06207513
Single-used Versus MultiPlE-used Endotracheal suCtIon cAtheters in Mechanically ventiLated ICU Patients (SPECIAL-ICU)
Single-used Versus MultiPlE-used Endotracheal suCtIon cAtheters in Mechanically ventiLated ICU Patients: the SPECIAL-ICU Trial
In low and middle-income countries, open endotracheal suction catheters are used multiple times to perform suctioning due to limited resources [1,2]. Currently, there is limited evidence for using a new suction catheter for each suction pass, acknowledged in a review article of endotracheal suction procedures in paediatric populations [3]. Additionally, the latest artificial airway suctioning practice guidelines published by the American Association for Respiratory Care in 2022 did not mention any recommendations regarding suction catheter changing frequency [4]. The guidelines adopted a study conducted in 2001 which showed that reusing an open tracheal suctioning catheter is safe and cost effective [5]. Therefore, the current evidence of reusing suctioning catheters remains unclear, which rationalize the reason why some resource limited Intensive Care Units (ICUs) use the catheter multiple times during a 12-hour shift, and possibly explain the high ventilator associated pneumonia (VAP) incidence in these ICUs [1,2].
Therefore, this feasibility study will propose to explore whether single-used suction catheters or multiple used open endotracheal tracheal suctioning catheters flushed with chlorhexidine are associated with reduced VAP incidence and its impact on mechanically ventilated patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dkahliya
-
Mansoura, Dkahliya, Egypt, 33156
- Mansoura University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients (aged ≥ 18 years old) who are admitted to the ICU, intubated with an endotracheal tube and receiving mechanical ventilation support directly after intubation with an expected mechanical ventilation support of at least 48 hours.
- All adults' patients meeting the above criteria whose relatives agree for them to be part of the study via deferred consent process
Exclusion Criteria:
- Patients who have received already standard care at ICU admission (the use of an endotracheal suction catheter multiple times during endotracheal suction procedures)
- Patients with contraindications to endotracheal suctioning procedure such as increased intracranial pressure, severe haemoptysis, and cerebrospinal fluid leaks.
- Patients who are previously intubated during the current hospital admission.
- Patients expected to receive mechanical ventilation less than 72 hours.
- Patients diagnosed with pneumonia at ICU admission.
- Patients having a Modified Clinical Pulmonary Infection Score (MCPIS) of 5 or greater.
- Patients with atelectasis, ARDS, and pulmonary oedema.
- Patients known to be allergic to chlorhexidine.
- Patients whose family (next-of-kin) have not provided deferred consent within 48 hours after ICU admission will be excluded and standard care will be provided.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention I group
Patient intubated with an endotracheal tube and on a mechanical ventilator will receive endotracheal suctioning procedure using a single-used open endotracheal suction catheter that is used only for one-time suctioning attempt and discarded after each endotracheal suction cycle.
A new catheter will be used for each endotracheal suctioning procedure.
|
Patient intubated with an endotracheal tube and on a mechanical ventilator will receive endotracheal suctioning procedure using an open endotracheal suction catheter that is used multiple times during a 12-hour nursing shift.
Flushing of the suctioning circuit will be performed with 40 ml of chlorhexidine gluconate 0.2% after every endotracheal suction procedure
|
|
Experimental: Intervention II group
Patient intubated with an endotracheal tube and on a mechanical ventilator will receive endotracheal suctioning procedure using an open endotracheal suction catheter that is used multiple times during a 12-hour nursing shift.
Flushing of the suctioning circuit will be performed with 40 ml of chlorhexidine gluconate 0.2% after every endotracheal suction procedure
|
Patient intubated with an endotracheal tube and on a mechanical ventilator will receive endotracheal suctioning procedure using an open endotracheal suction catheter that is used multiple times during a 12-hour nursing shift.
Flushing of the suctioning circuit will be performed with 40 ml of chlorhexidine gluconate 0.2% after every endotracheal suction procedure
|
|
Other: Control group
Patients intubated with an endotracheal tube and on a mechanical ventilator will receive standard care.
This is the endotracheal suctioning procedure using an open endotracheal suction catheter that is used multiple times during a 12-hour nursing shift.
Flushing of the suctioning circuit is standardised performed using normal saline after every endotracheal suction procedure.
|
Patient intubated with an endotracheal tube and on a mechanical ventilator will receive endotracheal suctioning procedure using an open endotracheal suction catheter that is used multiple times during a 12-hour nursing shift.
Flushing of the suctioning circuit will be performed with 40 ml of chlorhexidine gluconate 0.2% after every endotracheal suction procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of intervention
Time Frame: through study completion, an average of 1 year
|
The feasibility and acceptability of the proposed intervention among healthcare professionals in study settings and determine methods for the design of a conclusive randomized controlled trial.
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients outcome
Time Frame: through study completion, an average of 1 year
|
Will measure the impact of the proposed intervention on mechanically patients outcomes including Ventilator associated pneumonia incidence (using the modified clinical pulmonary infection score) and length of ICU stay
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Healthcare-Associated Pneumonia
- Pathologic Processes
- Disease Attributes
- Respiratory Tract Infections
- Infections
- Respiratory Tract Diseases
- Lung Diseases
- Pneumonia
- Cross Infection
- Iatrogenic Disease
- Pneumonia, Ventilator-Associated
- Anti-Infective Agents
- Anti-Infective Agents, Local
- Disinfectants
- Chlorhexidine
Other Study ID Numbers
- 4112023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Associated Pneumonia
-
Giovanna Marssola NascimentoMinistry of Health, BrazilCompletedHealthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated InfectionBrazil
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Cubist Pharmaceuticals LLCCompletedLung Diseases | Healthcare-Associated Pneumonia | Ventilator-Associated Pneumonia
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Hospital OlomoucCompletedVentilator-Associated Pneumonia
-
Aydin Adnan Menderes UniversityNot yet recruitingVentilator-Associated PneumoniaTurkey
-
University Hospital, ToulouseRecruitingVentilator-associated PneumoniaFrance
-
Erasmus Medical CenterChiesi Farmaceutici S.p.A.CompletedVentilator Associated Pneumonia (VAP)Spain, Netherlands
-
Andrzej Frycz Modrzewski Krakow UniversityCompletedVAP - Ventilator Associated PneumoniaPoland
-
Assistance Publique - Hôpitaux de ParisUnknownVentilator-associated PneumoniaFrance
Clinical Trials on Suction Circuit Flushing with Chlorhexidine
-
Mansoura UniversityCompletedVentilator Associated PneumoniaEgypt
-
Centre Hospitalier Intercommunal de Toulon La Seyne...RecruitingMechanical VentilationFrance
-
Shanghai Pudong New Area Gongli HospitalNot yet recruitingAcute Ischemic Stroke | Stroke-Associated Pneumonia (SAP)China
-
Weill Medical College of Cornell UniversityCompleted
-
Koç UniversityKoç University HospitalCompletedIntubation | Infection | Intubation Complication | Intensive Care (ICU)Turkey (Türkiye)
-
Asan Medical CenterCompletedPancreatic MassesKorea, Republic of
-
Radboud University Medical CenterCompletedPeritoneal CarcinomatosisNetherlands
-
University of SaskatchewanCompleted
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownAcute Respiratory FailureItaly